Today: 30 June 2026
Newmont stock whipsaws on gold crash — what traders watch before Tuesday’s open
3 February 2026
1 min read

Newmont stock whipsaws on gold crash — what traders watch before Tuesday’s open

New York, Feb 2, 2026, 21:19 (EST) — Market closed

  • Newmont shares closed a bit up following a choppy session marked by wild swings in bullion prices.
  • Gold and silver plunged further following new margin increases and a change in Fed forecasts.
  • Attention shifts to Tuesday’s metals sentiment, Friday’s U.S. jobs report, and Newmont’s results on Feb. 19.

Newmont shares ended Monday up 0.45%, closing at $112.85. The stock fluctuated between $110.48 and $116.25 as traders reacted to bullion’s late-session moves.

The stock’s close connection to gold grabbed attention again after an unusual two-day swing in precious metals. Gold tumbled roughly 5% on Monday, with silver plunging over 7%, following a historic selloff on Friday. The selloff came after Donald Trump nominated Kevin Warsh to replace Jerome Powell at the Federal Reserve—a shift some traders viewed as hawkish.

CME Group pushed prices further by raising margin requirements for precious-metals futures, with the new, higher cash deposits kicking in after Monday’s close. “Gold and silver are on a rollercoaster ride,” said John Meyer, analyst at SP Angel. Deutsche Bank’s Michael Hsueh added that the market conditions don’t seem “primed for a sustained reversal” in gold. Reuters

Newmont slid in premarket action as the metals sell-off hammered miners. Daniela Hathorn of Capital.com pointed to thin liquidity and “heightened sensitivity” to headlines as factors driving sharp intraday moves. Kitco

Stock moves in names like Newmont hinge on these mechanics. When futures margins climb, leveraged traders face pressure to add cash or trim positions. That often triggers swift selling in metals, sparking sharp knock-on effects in miners investors treat as liquid stand-ins.

JPMorgan Chase remains bullish on gold over the long haul, forecasting that central-bank and investor demand will push prices up to $6,300 an ounce by the end of 2026. This comes even after last week’s dip from record highs.

The downside scenario is straightforward: if bullion continues to fall and the dollar remains strong, miners’ operating leverage turns against them. For Newmont, even a hint that costs are outpacing prices or production falls short could drag the stock down, regardless of gold prices holding steady.

Tuesday’s focus: will gold and silver hold steady after the CME bumped up margins? The bigger macro event this week lands Friday with the U.S. employment report.

Next up for Newmont: the company plans to publish its Q4 and full-year 2025 results once North American markets close on Feb. 19. A conference call will follow at 5:30 p.m. EST.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Johnson & Johnson stock rises as new Erleada survival data lands
Previous Story

Johnson & Johnson stock rises as new Erleada survival data lands

Amphenol stock price steadies near $145 after earnings whipsaw as traders eye Tuesday’s U.S. shutdown vote
Next Story

Amphenol stock price steadies near $145 after earnings whipsaw as traders eye Tuesday’s U.S. shutdown vote

Go toTop